Physician profile
Isaac P Humphrey
NPI 1649357724
$223,703.27
in general payments reported to CMS, 2019-2025
6 companies · $73K in 2025
The $73K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $23K · 2021: $26K · 2022: $27K · 2023: $29K · 2024: $33K · 2025: $73K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $64K · Travel and Lodging: $45K · Consulting Fee: $21K · Food and Beverage: $3,085 · Honoraria: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $64,250.00 |
| Travel and Lodging | $44,968.52 |
| Consulting Fee | $20,800.00 |
| Food and Beverage | $3,085.05 |
| Honoraria | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $223,380.15 | 2019-2025 | Lifevest |
| Esperion Therapeutics, INC. | $124.80 | 2020 | |
| Sanofi-Aventis U.S. LLC | $123.66 | 2019 | |
| Janssen Pharmaceuticals, INC | $33.36 | 2024 | Xarelto |
| Abiomed | $22.41 | 2024 | Impella |
| Novartis Pharmaceuticals Corporation | $18.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isaac Humphrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.